高级别浆液性卵巢癌的长期生存者是谁
本文综述了与高级别浆液性卵巢癌长期生存(通常定义为初诊后生存超过7至10年)相关的临床与基因组特征。大型回顾性人群研究发现长期生存与年轻、早期分期、低级别、非浆液性组织学、无腹水、初次减灭手术及理想减瘤相关;胚系BRCA突变与短期化疗敏感性相关但未改善长期生存;六项独立基因表达分析识别的生存相关基因集各不相同。
要点
- 长期生存通常定义为初诊后生存超过7至10年。
- 临床特征如年轻、早期分期、低级别、非浆液性组织学、无腹水、初次减灭手术及理想减瘤与长期生存相关。
- 胚系BRCA突变与短期化疗敏感性相关,但未改善长期生存。
核心结论
- 进一步阐明长期生存的相关因素有助于理解卵巢癌生物学,以改善所有上皮性卵巢癌患者的生存。
研究设计与样本
- 综述,检索范围未明确报告。
主要发现
- 约15%的上皮性卵巢癌患者生存超过10年。
- 长期生存与初诊时较年轻、较早的临床病理分期、较低级别、非浆液性组织学、无腹水、初次减灭手术及初次手术理想减瘤相关。
- 复发后生存时间也影响长期生存,取决于复发部位及对后续化疗或手术的反应。
- 胚系BRCA突变与短期化疗敏感性相关,但似乎未改善长期生存。
- 六项独立的长期生存者基因表达分析均识别出与生存延长相关的特征,但每项研究识别的基因集不同。
关键数值与推荐
- 长期生存通常定义为初诊后生存超过7至10年。
- 长期生存者肿瘤中差异表达的基因广泛涉及细胞增殖、肿瘤-间质相互作用、细胞骨架、营养物质代谢及免疫/应激反应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 上皮性卵巢癌中复发性体细胞突变相对缺乏,使得识别与长期生存相关的基因组特征困难。
- 六项长期生存者基因表达分析各自识别的基因集不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although the median survival for epithelial ovarian cancer (EOC) is <5years, approximately 15% of patients will survive for >10years. A better understanding of these exceptional responders could reveal opportunities to improve the dismal prognosis of most EOC patients. In this review, we examine the clinical and genomic features that have been associated with long-term survival, which is generally defined as survival of >7-10years after initial diagnosis. Clinical features influencing long-term survival have been best reported in large retrospective population-based studies. These studies find that long-term survival is associated with previously validated prognostic factors, including younger age at diagnosis, earlier clinicopathologic stage, lower grade, non-serous histology, absence of ascites, primary debulking surgery, and optimal cytoreduction at primary surgery. Duration of survival after a recurrence also contributes to long-term survival and depends both on recurrence location and response to subsequent chemotherapy or surgery. Germline BRCA mutations, although associated with short-term chemosensitivity, do not appear to improve long-term survival. Unfortunately, the relative lack of recurrent somatic mutations in EOC has made the identification of genomic signatures associated with long-term survival difficult. Although six independent gene expression analyses of long-term survivors (LTS) have identified signatures associated with prolonged survival, different gene sets are identified in each study. Genes differentially expressed in tumors of LTS are broadly involved in cell proliferation, tumor-stromal interactions, the cytoskeleton, metabolism of nutrients, and immune/stress response. We anticipate that consistent selection of control and LTS groups, combined with the use of emerging transcriptomic, epigenomic, and proteomic platforms, is likely to identify conserved features associated with long-term survival. Further elucidating the factors contributing to long-term survival has the potential to contribute to our understanding of the biology of ovarian cancer, with the goal of improving the survival of all EOC patients.
引用
- Hoppenot C, Eckert MA, Tienda SM, et al. Who are the long-term survivors of high grade serous ovarian cancer? Gynecol Oncol. 2017. PMID: 29128106. doi:10.1016/j.ygyno.2017.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。